Logo - springer
Slogan - springer

Medicine - Radiology | Annals of Nuclear Medicine – incl. option to publish open access (Press)

Annals of Nuclear Medicine

Annals of Nuclear Medicine

Editor-in-Chief: Seigo Kinuya

ISSN: 0914-7187 (print version)
ISSN: 1864-6433 (electronic version)

Journal no. 12149

$99.00 Personal Rate e-only for the Americas
Get Subscription

Online subscription, valid from January through December of current calendar year

Immediate access to this year's issues via SpringerLink

1 Volume(-s) with 10 issue(-s) per annual subscription

Automatic annual renewal

More information: >> FAQs // >> Policy

18 July 2018

Hisada Prize

2018 Hisada Prize Winners 

Announcement of the Award for the Best Paper (Hisada Prize) 

Dr. Kinichi Hisada, an honorary member of the Japanese Society of Nuclear Medicine,has annually contributed a million yen to the Society since 2009 to promote the development of the Annals of Nuclear Medicine. An award for the Best Paper was renamed the “Hisada Prize” in appreciation for his contribution. The best three papers are selected from the original articles and technical notes published in the Annals of Nuclear Medicine every year.
The first paper (Gold Prize) will receive a prize of 300,000 yen, the second paper (Silver Prize) one of 200,000 yen, and the third paper (Bronze Prize) one of 150,000 yen.
1) The awardees must be a member of the Japanese Society of Nuclear Medicine, provided they are Japanese nationals or foreign residents of Japan.
2) A foreign winner living overseas of Japan is not necessarily a member of the Japanese Society of Nuclear Medicine.
3) The awardees must be able to attend the Annual Meeting of the Japanese Society of Nuclear Medicine in the reference year and have a poster presentation. In case the awardees will not be able to attend the meeting, their representatives may do it.
Jun Hatazawa,
Chairperson of Board of Directors
Seigo Kinuya

For authors and editors

  • Journal Citation Reports®
    2017 Impact Factor
  • 1.656
  • Aims and Scope

    Aims and Scope


    Annals of Nuclear Medicine is an official journal of the Japanese Society of Nuclear Medicine (JSNM) whose main aim is to develop the appropriate application of radioactive substances and stable nuclides in the field of medicine. To that end, this journal promotes the exchange of ideas and information and research in nuclear medicine as well.
    Papers on the medical application of radionuclides and related subjects are welcomed. Five types of papers are considered for publication: original articles, case reports, short communications, reviews, letters to the editor, and others. Submitted manuscripts are reviewed in terms of originality, significance, and adequacy of documentation.

  • Submit Online
  • Open Choice - Your Way to Open Access
  • Instructions for Authors

    Instructions for Authors


  • Certification Form (pdf, 183 kB)
  • Conflict of Interest Form (pdf, 142 kB)
  • Instructions for Reviewers (pdf, 16 kB)
  • Policy of ANM on duplicate submission (p...
  • Policy of Institutional Repository (pdf,...
  • English Language Editing

    English Language Editing


  • Author Academy: Training for Authors
  • Copyright Information

    Copyright Information


    For Authors

    Submission of a manuscript implies: that the work described has not been published before (except in form of an abstract or as part of a published lecture, review or thesis); that it is not under consideration for publication elsewhere; that its publication has been approved by all co-authors, if any, as well as – tacitly or explicitly – by the responsible authorities at the institution where the work was carried out.

    Author warrants (i) that he/she is the sole owner or has been authorized by any additional copyright owner to assign the right, (ii) that the article does not infringe any third party rights and no license from or payments to a third party is required to publish the article and (iii) that the article has not been previously published or licensed. The author signs for and accepts responsibility for releasing this material on behalf of any and all co-authors. Transfer of copyright to the Japanese Society of Nuclear Medicine becomes effective if and when a Copyright Transfer Statement is signed or transferred electronically by the corresponding author. After submission of the Copyright Transfer Statement signed by the corresponding author, changes of authorship or in the order of the authors listed will not be accepted by Springer.

    The copyright to this article, including any graphic elements therein (e.g. illustrations, charts, moving images), is assigned for good and valuable consideration to the Japanese Society of Nuclear Medicine effective if and when the article is accepted for publication and to the extent assignable if assignability is restricted for by applicable law or regulations (e.g. for U.S. government or crown employees).

    The copyright assignment includes without limitation the exclusive, assignable and sublicensable right, unlimited in time and territory, to reproduce, publish, distribute, transmit, make available and store the article, including abstracts thereof, in all forms of media of expression now known or developed in the future, including pre- and reprints, translations, photographic reproductions and microform. Springer may use the article in whole or in part in electronic form, such as use in databases or data networks for display, print or download to stationary or portable devices. This includes interactive and multimedia use and the right to alter the article to the extent necessary for such use.

    Authors may self-archive the Author’s accepted manuscript of their articles on their own websites. Authors may also deposit this version of the article in any repository, provided it is only made publicly available 12 months after official publication or later. He/she may not use the publisher's version (the final article), which is posted on SpringerLink and other Springer websites, for the purpose of self-archiving or deposit. Furthermore, the Author may only post his/her version provided acknowledgement is given to the original source of publication and a link is inserted to the published article on Springer's website. The link must be accompanied by the following text: "The final publication is available at link.springer.com”.

    Prior versions of the article published on non-commercial pre-print servers like arXiv.org can remain on these servers and/or can be updated with Author's accepted version. The final published version (in pdf or html/xml format) cannot be used for this purpose. Acknowledgement needs to be given to the final publication and a link must be inserted to the published article on Springer's website, accompanied by the text "The final publication is available at link.springer.com". Author retains the right to use his/her article for his/her further scientific career by including the final published journal article in other publications such as dissertations and postdoctoral qualifications provided acknowledgement is given to the original source of publication.

    Author is requested to use the appropriate DOI for the article. Articles disseminated via link.springer.com are indexed, abstracted and referenced by many abstracting and information services, bibliographic networks, subscription agencies, library networks, and consortia.

    For Readers

    While the advice and information in this journal is believed to be true and accurate at the date of its publication, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may have been made. The publisher makes no warranty, express or implied, with respect to the material contained herein.

    All articles published in this journal are protected by copyright, which covers the exclusive rights to reproduce and distribute the article (e.g., as offprints), as well as all translation rights. No material published in this journal may be reproduced photographically or stored on microfilm, in electronic data bases, video disks, etc., without first obtaining written permission from the Japanese Society of Nuclear Medicine. The use of general descriptive names, trade names, trademarks, etc., in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

    Springer has partnered with Copyright Clearance Center’s RightsLink service to offer a variety of options for reusing Springer content. For permission to reuse our content please locate the material that you wish to use on link.springer.com or on SpringerImages.com and click on the permissions link or go to copyright.com and enter the title of the publication that you wish to use. For assistance in placing a permission request, Copyright Clearance Center can be connected directly via phone: +1-855-239-3415, fax: +1-978-646-8600, or e-mail: info@copyright.com.


    © The Japanese Society of Nuclear Medicine

Services for the Journal

Alerts for this journal


Get the table of contents of every new issue published in Annals of Nuclear Medicine.